Fulgent Genetics, INC Form 4 insider transactions

CFO and Treasurer of Fulgent Genetics, Paul Kim, reports the withholding of 3,000 common stock shares to cover tax obligations related to vesting restricted stock units.

Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations and indirect ownership through a family trust.

Fulgent Genetics CFO and Treasurer, Paul Kim, sold 1,553 shares of common stock to cover tax obligations related to vesting restricted stock units.

Fulgent Genetics' President and COO, Jian Xie, sold 1,455 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,373 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Fulgent Genetics CEO Ming Hsieh sold 2,227 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Fulgent Genetics CFO and Treasurer, Paul Kim, sold 669 shares of common stock to cover tax obligations related to vested restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 497 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Fulgent Genetics' President and COO, Jian Xie, sold 689 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Fulgent Genetics CEO Ming Hsieh reports the withholding of shares to cover tax obligations and details beneficial ownership through various trusts and custodial accounts.

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, reports a transaction involving the withholding of shares to cover tax obligations.

Chief Scientific Officer of Fulgent Genetics, Gao Hanlin, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Paul Kim, CFO and Treasurer of Fulgent Genetics, reports the withholding of shares to cover tax obligations arising from vesting restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

Fulgent Genetics CFO Paul Kim sold 1,674 shares of common stock on September 3, 2024, to cover tax obligations arising from the vesting of restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, sold 1,594 shares of common stock on September 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,503 shares of common stock on September 3, 2024, to cover tax obligations arising from the vesting of restricted stock units.

Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, sold 563 shares of common stock on August 27, 2024, to satisfy tax withholding obligations related to vesting restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, sold 715 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Fulgent Genetics CEO Ming Hsieh sold 2,313 shares of common stock on August 27, 2024, to cover tax obligations arising from the vesting of restricted stock units.

Fulgent Genetics CFO Paul Kim sold 733 shares of common stock on August 27, 2024, to satisfy tax withholding obligations related to vesting restricted stock units.

CFO of Fulgent Genetics, Paul Kim, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.

CEO Ming Hsieh reports disposition of shares to cover tax obligations and details beneficial ownership through trusts and custodial accounts.

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, reports the disposal of 111 shares of common stock to cover tax obligations.

Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Fulgent Genetics' CFO, Paul Kim, reports the withholding of shares to cover tax obligations arising from vested restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Gao Hanlin, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, reported disposing of shares to cover tax withholding obligations related to vested restricted stock units.